体外膜肺氧合在围术期及危重症患者中的应用进展  

Application progress of extracorporeal membrane oxygenation in perioperative critical patients

作　　者：王卓[1] 张静[1] 杨艳[2] 詹丽英[2] WANG Zhuo;ZHANG Jing;YANG Yan;ZHAN Liying(Department of Anesthesiology,Renmin Hospital of Wuhan University,Wuhan 430060,China)

机构地区：[1]武汉大学人民医院麻醉科,430060 [2]武汉大学人民医院重症医学科,430060

出　　处：《临床麻醉学杂志》2022年第2期213-216,共4页Journal of Clinical Anesthesiology

基　　金：湖北省中央引导地方科技发展专项(2020ZYYD001)。

摘　　要：体外膜肺氧合(ECMO)作为一种改良的体外生命支持技术,可部分或完全替代患者的心肺功能,为常规治疗策略无效的顽固性心力衰竭和呼吸衰竭患者提供长时间体外心肺支持,使心肺脏器得到休息恢复,为救治原发病争取时间。经过长期的临床实践与不断探索,ECMO技术已取得长足进步。全文就ECMO的工作原理、围术期应用与急症救治作一综述。Extracorporeal membrane oxygenation as an improved in vitro life support technology,can partially or completely replace the patient s cardiopulmonary function,for conventional treatment strategy ineffective stubborn heart failure and exhalation patients to provide long-term in vitro cardiopulmonary support,so that the cardiopulmonary organs get rest and recovery,for the treatment of primary disease to buy valuable time.After long-term clinical practice and continuous exploration,extracorporeal membrane oxygenation technology has made great progress.This article summarizes and prospects the working principle,perioperative application and emergency treatment of extracorporeal membrane oxygenation.

关 键 词：体外膜肺氧合 体外生命支持 围术期应用 急症救治 

分 类 号：R614[医药卫生—麻醉学]